
Theranostics in Hematooncology A Deep Dive
Created on January 16, 2025
1
Explore cutting-edge advancements in theranostics for treating hematologic cancers like leukemia and lymphoma focusing on targeted therapies and radioimmunotherapy. We discuss the potential and limitations of CXCR4-targeted therapies and the importance of accessibility and safety.
Comments
Please log in to leave a comment.